{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:22:47Z","timestamp":1787930567410,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-15034-8","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:04:32Z","timestamp":1784707472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge, attitudes and practices of health care professionals towards pharmacovigilance in Georgia"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8694-7483","authenticated-orcid":false,"given":"Nino","family":"Silagadze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Darakhvelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-2166","authenticated-orcid":false,"given":"Elza","family":"Nikoleishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Katamadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterine","family":"Ruadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Ganugrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"15034_CR1","volume-title":"Fast facts on pharmacovigilance","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Fast facts on pharmacovigilance. Geneva, Switzerland: WHO; 2015."},{"key":"15034_CR2","volume-title":"Sciences, Engineering, and Medicine. Crossing the global quality chasm: improving health care worldwide","author":"National Academies of","year":"2018","unstructured":"National Academies of. Sciences, Engineering, and Medicine. Crossing the global quality chasm: improving health care worldwide. Washington, DC: National Academies; 2018."},{"key":"15034_CR3","volume-title":"The economics of patient safety: strengthening a value-based approach to reducing patient harm at national level","author":"L Slawomirski","year":"2017","unstructured":"Slawomirski L, Auraaen A, Klazinga N. The economics of patient safety: strengthening a value-based approach to reducing patient harm at national level. Paris, France: OECD; 2017."},{"key":"15034_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/qshc.2007.023622","volume":"17","author":"EN De Vries","year":"2008","unstructured":"De Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17:216\u201323. https:\/\/doi.org\/10.1136\/qshc.2007.023622.","journal-title":"Qual Saf Health Care"},{"key":"15034_CR5","volume-title":"The importance of pharmacovigilance: safety monitoring of medicinal products","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. The importance of pharmacovigilance: safety monitoring of medicinal products. Geneva, Switzerland: WHO; 2002."},{"key":"15034_CR6","volume-title":"The safety of medicines in public health programmes: pharmacovigilance an essential tool","author":"Quality Assurance and Safety of Medicines Team (WHO)","year":"2006","unstructured":"Quality Assurance and Safety of Medicines Team (WHO). The safety of medicines in public health programmes: pharmacovigilance an essential tool. Geneva, Switzerland: WHO; 2006."},{"key":"15034_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/s0278-5846(82)80162-0","volume":"6","author":"CA Naranjo","year":"1982","unstructured":"Naranjo CA, Busto U, Sellers EM. Difficulties in assessing adverse drug reactions in clinical trials. Prog Neuropsychopharmacol Biol Psychiatry. 1982;6:651\u20137. https:\/\/doi.org\/10.1016\/s0278-5846(82)80162-0.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"15034_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2105\/ajph.2007.124537","volume":"98","author":"JA Berlin","year":"2008","unstructured":"Berlin JA, Glasser SC, Ellenberg SS. Adverse event detection in drug development: recommendations and obligations beyond phase 3. Am J Public Health. 2008;98:1366\u201371. https:\/\/doi.org\/10.2105\/ajph.2007.124537.","journal-title":"Am J Public Health"},{"key":"15034_CR9","volume-title":"WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems. Geneva, Switzerland: WHO; 2015."},{"key":"15034_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.15537\/smj.2016.12.17059","volume":"37","author":"NB Almandil","year":"2016","unstructured":"Almandil NB. Healthcare professionals\u2019 awareness and knowledge of adverse drug reactions and pharmacovigilance. Saudi Med J. 2016;37:1359\u201364. https:\/\/doi.org\/10.15537\/smj.2016.12.17059.","journal-title":"Saudi Med J"},{"issue":"5","key":"15034_CR11","doi-asserted-by":"publisher","first-page":"e0285811","DOI":"10.1371\/journal.pone.0285811","volume":"18","author":"Y Erg\u00fcn","year":"2023","unstructured":"Erg\u00fcn Y, Bilen \u00d6, \u00c7elik HT, Karakaya G, Demirkan K. Knowledge, attitudes, practices, and barriers regarding pharmacovigilance and adverse drug reaction reporting among healthcare professionals in T\u00fcrkiye: A cross-sectional study. PLoS ONE. 2023;18(5):e0285811. https:\/\/doi.org\/10.1371\/journal.pone.0285811.","journal-title":"PLoS ONE"},{"key":"15034_CR12","first-page":"17","volume-title":"05\/05\/1997","author":"Parliament of Georgia","year":"1997","unstructured":"Parliament of Georgia. Law of Georgia on medicines and pharmaceutical activities. 05\/05\/1997. Georgia: Parliamentary Gazette; 1997. pp. 17\u20138."},{"key":"15034_CR13","unstructured":"Agency for the. Medical and Pharmaceutical Activities. Report of the regulation. 2021."},{"key":"15034_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2125.1995.tb04440.x","volume":"39","author":"KJ Belton","year":"1995","unstructured":"Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39:223\u20136. https:\/\/doi.org\/10.1111\/j.1365-2125.1995.tb04440.x.","journal-title":"Br J Clin Pharmacol"},{"key":"15034_CR15","unstructured":"Olowofela A. Evaluation of pharmacovigilance system performance in South- South Nigeria, Doctoral thesis. Bordeaux, France: Universit\u00e9 de Bordeaux; 2018."},{"key":"15034_CR16","unstructured":"Djibouti S. A situational analysis of pharmacovigilance system in Georgia, Master\u2019s thesis. Tallinn, Estonia: Tallinn University of Technology; 2018."},{"issue":"2","key":"15034_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7176.116232","volume":"35","author":"J Charan","year":"2013","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in medical research. Indian J Psychol Med. 2013;35(2):121\u20136.","journal-title":"Indian J Psychol Med"},{"key":"15034_CR18","volume-title":"Survey sampling","author":"L Kish","year":"1965","unstructured":"Kish L. Survey sampling. New York: Wiley; 1965."},{"key":"15034_CR19","unstructured":"KoBoToolbox. KoBoToolbox: data collection tools for challenging environments. Cambridge (MA): Harvard Humanitarian Initiative. 2023. Available from: https:\/\/www.kobotoolbox.org"},{"key":"15034_CR20","volume-title":"Taxonomy of educational objectives: The classification of educational goals. Handbook I: Cognitive domain","author":"BS Bloom","year":"1956","unstructured":"Bloom BS. Taxonomy of educational objectives: The classification of educational goals. Handbook I: Cognitive domain. New York: David McKay Company; 1956."},{"issue":"4","key":"15034_CR21","first-page":"268","volume":"53","author":"M Ramesh","year":"2021","unstructured":"Ramesh M, Parthasarathi G, Muthukumar P. Impact of educational interventions on knowledge and practice of pharmacovigilance among healthcare professionals in a tertiary care hospital in India. Indian J Pharmacol. 2021;53(4):268\u201373.","journal-title":"Indian J Pharmacol"},{"key":"15034_CR22","doi-asserted-by":"publisher","unstructured":"Rehan HS, Sah RK, Chopra D. Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital. Indian J Pharmacol. 2012 Nov-Dec;44(6):699\u2013703. https:\/\/doi.org\/10.4103\/0253-7613.103253.","DOI":"10.4103\/0253-7613.103253"},{"issue":"2","key":"15034_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/1574886318666230428144120","volume":"19","author":"S Shukla","year":"2024","unstructured":"Shukla S, Sharma P, Gupta P, et al. Current scenario and future prospects of adverse drug reaction monitoring and reporting mechanisms in the rural areas of India. Curr Drug Saf. 2024;19(2):172\u201390.","journal-title":"Curr Drug Saf"},{"key":"15034_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4172\/2329-6887.1000135","volume":"2","author":"SM Mulatu","year":"2014","unstructured":"Mulatu SM, Worku A. Assessment of knowledge, attitude and practice of health professionals towards adverse drug reaction reporting and factors associated with reporting. J Pharmacovigil. 2014;2:135. https:\/\/doi.org\/10.4172\/2329-6887.1000135.","journal-title":"J Pharmacovigil"},{"issue":"1","key":"15034_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/2229-3485.148816","volume":"6","author":"SK Gupta","year":"2015","unstructured":"Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45\u201352.","journal-title":"Perspect Clin Res"},{"issue":"5","key":"15034_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385\u201396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003.","journal-title":"Drug Saf"},{"issue":"11","key":"15034_CR27","doi-asserted-by":"publisher","first-page":"e005869","DOI":"10.1136\/bmjopen-2014-005869","volume":"4","author":"M Pirmohamed","year":"2014","unstructured":"Pirmohamed M, Atuhaire J, Dodoo A, Olsson S, Pal SN, Dodoo ANO. Recognition and reporting of suspected adverse drug reactions by healthcare professionals in Uganda: a cross-sectional study. BMJ Open. 2014;4(11):e005869.","journal-title":"BMJ Open"},{"issue":"12","key":"15034_CR28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/BF03262002","volume":"35","author":"L Aagaard","year":"2012","unstructured":"Aagaard L, Strandell J, Melskens L, Petersen PSG, Hansen EH. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase. Drug Saf. 2012;35(12):1171\u201382.","journal-title":"Drug Saf"},{"issue":"12","key":"15034_CR29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.15537\/smj.2016.12.17059","volume":"37","author":"NB Almandil","year":"2016","unstructured":"Almandil NB. Healthcare professionals\u2019 awareness and knowledge of adverse drug reactions and pharmacovigilance. Saudi Med J. 2016;37(12):1359\u201364.","journal-title":"Saudi Med J"},{"issue":"3","key":"15034_CR30","first-page":"187","volume":"18","author":"RA Putri","year":"2023","unstructured":"Putri RA, Ikawati Z, Yasin NM. An awareness of pharmacovigilance among healthcare professionals: a systematic review. Curr Drug Saf. 2023;18(3):187\u2013200.","journal-title":"Curr Drug Saf"},{"key":"15034_CR31","volume-title":"Pharmacovigilance: ensuring drug safety worldwide","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Pharmacovigilance: ensuring drug safety worldwide. Geneva, Switzerland: WHO; 2020."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-15034-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:43:18Z","timestamp":1787928198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-15034-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15034"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-15034-8","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. We explained the purpose of the survey to potential participants, and they were requested to provide consent for voluntary participation before answering the questions. The questionnaire was anonymous to ensure confidentiality. This study was approved by the Biomedical Research Ethics Committee, University of Georgia, School of Health Sciences [N 11 -15688].","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1196"}}